Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us
Pipeline News and Updates
Picture

Semaglutide PIONEER Trials

6/20/2019

 
Novo Nordisk designed the ten trial Phase III PIONEER program to support the NDA for oral semaglutide for the treatment of type 2 diabetes. If approved, semaglutide will be the first oral GLP-1 receptor agonist and will likely become a preferred treatment to add to patients that are inadequately controlled with metformin. There are links to seven published studies in the Pharmaceutical Pipeline Tracker.
 
Following are summaries of what we know about the ten trials.
  • PIONEER -1: lowered HbA1c 1.1% more than placebo. 
  • PIONEER -2*: lowered HbA1c 1.3% compared to 0.8% with empagliflozin in patients inadequately controlled on metformin. 
  • PIONEER -3: lowered HbA1c 0.5% and decreased weight 1.6kg to 2.5kg more than sitagliptin in patients inadequately controlled on metformin with or without a sulfonylurea. 
  • PIONEER -4: lowered HbA1c 1.2% compared to a 1.1% reduction with liraglutid. 
  • PIONEER -5: lowered HbA1c 1.0% and lost 3.4 kg compared to a HbA1c decrease of 0.2% and 0.9 kg loss with placebo in patients with moderate renal impairment. 
  • PIONEER-6: non-inferior to placebo in the occurrence of a combined endpoint of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke compared to placebo (3.8% occurrence vs 4.8%) when added to standard care in patients with type 2 diabetes. 
  • PIONEER -7: 58% achieved an HbA1c < 7% compared to 25% with sitagliptin.
  • PIONEER -8: lowered HbA1c 1.2% and a weight loss of 4.3 kg compared to no improvement in HbA1c and a 0.6 kg weight gain with placebo. 
  • PIONEER -9*:  lowered HbA1c compared to a 1.4% reduction with liraglutide in Japanese patients. 
  • PIONEER -10*: lowered HbA1c 1.8% and a weight loss of 1.9 kg compared to a 1.3% HbA1c reduction and a 1.1 kg weight gain with dulaglutide in Japanese patients.
* Results have been announced, but not published

Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    January 2023
    December 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.